Amlodipine besylate and Olmesartran medoxomil (Alembic Pharmaceuticals Limited)
Welcome to the PulseAid listing for the Amlodipine besylate and Olmesartran medoxomil drug offered from Alembic Pharmaceuticals Limited. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alembic Pharmaceuticals Limited |
NON-PROPRIETARY NAME: | Amlodipine besylate and Olmesartran medoxomil |
SUBSTANCE NAME: | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-07-18 |
END MARKETING DATE: | 0000-00-00 |
Amlodipine besylate and Olmesartran medoxomil HUMAN PRESCRIPTION DRUG Details:
Item Description | Amlodipine besylate and Olmesartran medoxomil from Alembic Pharmaceuticals Limited |
LABELER NAME: | Alembic Pharmaceuticals Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 20(mg/1; mg/1) |
START MARKETING DATE: | 2017-07-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 46708-212_cb2df7f7-fee8-42ba-8936-0788c4fcc0cb |
PRODUCT NDC: | 46708-212 |
APPLICATION NUMBER: | ANDA207073 |
Other AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers: